Liu et al. [53] created a novel multifunctional polymeric NP contrast agent modified with both anti-vascular endothelial growth factor (VEGF) and gadolinium-diethylenetriaminepentaacetic acid antibodies for the early diagnosis of HCC. Here, VEGFA is linked to hepatocellular carcinoma.